Picture of Waverley Pharma logo

WAVE Waverley Pharma Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Waverley Pharma, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments1.480.710.1580.1340.053
Net Total Accounts Receivable
Net Total Receivables0.9270.4560.7020.1930.138
Total Inventory
Prepaid Expenses
Total Current Assets2.541.681.450.6330.417
Net Intangible Assets
Other Long Term Assets
Total Assets4.393.493.682.690.952
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1.551.411.891.62.09
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities1.551.451.891.62.09
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity2.852.041.791.09-1.14
Total Liabilities & Shareholders' Equity4.393.493.682.690.952
Total Common Shares Outstanding